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Introduction: Primary involvement of the salivary glands in small cell carcinoma is rare, and has one of the worst
prognoses of salivary gland neoplasms. However, it has been reported that some cases have a favorable outcome,
although the prognostic factors are still under consideration. Multidisciplinary therapy was usually required to
achieve long-term survival. Recently, a resemblance of some small cell carcinomas of the salivary gland to
cutaneous Merkel cell carcinoma was suggested; the latter have the potential for spontaneous regression, which is
related to a favorable clinical outcome.
Case presentation: We present a locoregional advanced parotid small cell carcinoma with multiple lymph node
metastases in an 87-year-old Asian woman. The tumor was controlled by surgery alone, and nine-year disease-free
survival was achieved without any adjunctive therapy. To the best of our knowledge, this is the longest reported
follow-up of head and neck small cell carcinoma.
Conclusion: We believe this to be the first case of small cell carcinoma with involvement of the salivary glands
reported in the literature with a good outcome after surgery alone without any adjunctive therapy.Introduction
Primary involvement of the salivary glands in small cell
carcinoma (SmCC) is rare, and tumors in the salivary
glands account for less than 1% of all carcinomas of the
parotid gland and 3.5% of all malignant tumors of minor
salivary glands. This tumor has one of the worst progno-
ses of salivary gland neoplasms. The prognosis for
patients with SmCC of the salivary glands has been
reported to be more favorable than for those with SmCC
of other sites [1-4]. However, there is no doubt that par-
otid SmCC is a high-grade malignancy that should be
treated aggressively. Surgery, adjunctive radiation ther-
apy and/or chemotherapy have been performed in most
cases [1].
SmCCs of the salivary gland are classified into neuroen-
docrine types and ductal carcinomas. The neuroendocrine
type can be classified further into Merkel-cell-like SmCC* Correspondence: kanatake@omiya.jichi.ac.jp
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reproduction in any medium, provided the orand pulmonary variants, based on cytokeratin 20 immu-
noreactivity with a dot-like staining pattern [2]. Recently,
the resemblance of Merkel-cell-like SmCCs of salivary
gland to cutaneous Merkel cell carcinoma has been sug-
gested, and some of them have spontaneous regression
potential related to a favorable clinical outcome [1,2]. In
this article, we report a locoregional advanced parotid
SmCC that had an unusual clinical course. The tumor was
controlled by surgery alone, and nine-year disease-free
survival was achieved without any adjunctive therapy. We
also studied the expression of an oncogene or tumor
suppressor gene, and demonstrated the expression of
mammary serine protease inhibitor (Maspin), which is an
important tumor suppressor gene of salivary gland
carcinomas.
Case presentation
An 87-year-old Asian woman in good general health
presented with a progressively enlarging mass located
in her left preauricular region. Fine needle aspiration
(FNA) cytology analysis performed in the clinic suggestedral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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a rapid and consistent regression after FNA. During six
months of observation, the tumor regrew and the patient
was referred to our hospital.
A physical examination revealed a 55-mm tumor
located in the parotid with extension to the retroparotid
area, and swelling of her left laterocervical lymph node.
A computed tomography scan showed a peripheral
enhanced mass in her right parotid gland. Magnetic
resonance imaging revealed low signal intensity on
T1-weighted images and iso-high signal intensity on
T2-weighted images. The images showed the lesion to
be clearly circumscribed, with homogeneous hypo-iso
signal intensity on T1-weighted images and heteroge-
neous high signal intensity on T2-weighted images. The
tumor demonstrated circumscribed and heterogeneous
enhancement on gadolinium-enhanced T1-weighted
images (Figure 1). Computed tomography scans of her
thorax and abdomen did not reveal involvement of
other sites.
FNA was performed again and a cytological examin-
ation revealed a Papanicolaou classification of Class V,
suggesting SmCC. A total parotidectomy and modified
neck dissection were performed. On histopathology, the
tumor showed diffuse growth with confluent necrosis in
the salivary gland. The tumor cells had scant cytoplasm
and hyperchromatic nuclei without prominent nucleoli.
Mitotic figures were frequently observed (Figure 2).
Neoplasmic elements reveal positivity for cluster of
differentiation 56, neuron specific enolase, synaptophy-
sin and a dotted staining pattern with cytokeratin 20
(Figure 3). Based on our histopathological findings, a
diagnosis of a Merkel-cell-like SmCC of the parotidFigure 1 Magnetic resonance imaging scans. Magnetic resonance imag
homogeneous hypo-iso signal intensity on T1-weighted images and (B) he
and (D) coronal gadolinium-enhanced T1-weighted images show the presgland was made. Additional studies were positive for
Maspin.
Our patient’s postoperative course was uneventful, and
no postoperative radiotherapy was administered. The
nine-year clinical follow-up, which is the longest follow-
up of head and neck SmCC in our knowledge, revealed
no locoregional recurrence or distant metastasis.
Discussion
The parotid gland tumor in our case appeared on hist-
ology to be a SmCC. No tumor formation was recog-
nized in other locations; therefore, this was an extremely
rare primary SmCC of the parotid gland. This case also
has the longest follow-up to the best of our knowledge.
SmCC can occur in any organ, although the vast major-
ity occur in the lung. The prognosis for patients with
SmCC of the salivary glands has been reported to be more
favorable than for those with SmCC of the lung or larynx
[1,2,4]. However, there is no doubt that parotid SmCC is a
high-grade malignancy that should be treated aggressively.
The main treatment for parotid SmCC is a surgical ap-
proach with partial or total parotidectomy. The associ-
ation of radiotherapy with surgery has shown a decrease
in relapses and an increase in survival. Seventy-five per-
cent of local relapses occurred in cases where surgery had
been the only treatment, whereas, when associated with
radiotherapy, the rate of local relapse was 20% [1,5]. Our
case was controlled by surgery alone, and nine-year dis-
ease-free survival was achieved without any adjunctive
therapy despite the advanced nature of the disease.
Recently, two parotid SmCCs with unusual clinical
courses were reported. Mulder et al. presented a primary
SmCC of the parotid with massive local recurrence thating shows this lesion to be clearly circumscribed, with (A)
terogeneous high signal intensity on T2-weighted images. (C) Axial
ence of a circumscribed and heterogeneously enhanced tumor.
Figure 2 Histological features. (A) Diffuse growth with necrosis (lower right) of tumor cells is seen. Several residual ducts and glands are
observed in the tumor. (B) The tumor shares the features of small cell carcinomas seen in other organs. It is composed of small- to medium-sized
epithelioid cells with hyperchromatic, finely granular nuclei and scant cytoplasm. Mitotic figures are frequently seen.
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an advanced case where a complete response and long-
term survival was achieved by radiotherapy alone [5].
Both cases involved Merkel-cell-like SmCC. The neu-
roendocrine type of SmCC can be subdivided into
Merkel-cell-like and pulmonary varieties on the basis of
cytokeratin 20 immunoreactivity with a dot-like staining
pattern [7]. It has been speculated that some salivary
Merkel-cell-like SmCC are closely related biologically to
cutaneous Merkel cell carcinoma, which is known to be
less aggressive than extrasalivary SmCC [8]. One possi-
bility for a favorable clinical outcome after initial treat-
ment is the potential for spontaneous regression. We
could find one only case of spontaneous regression of a
salivary Merkel-cell-like SmCC [6], but spontaneous re-
gression of cutaneous Merkel cell carcinomas has been
described in 20 cases [9,10]. Furthermore, 10% to 20% of
all cases of metastasized cutaneous Merkel cell carcin-
omas present no obvious primary tumor [10]. It is not
known if the primary lesion had regressed in these cases.
The reasons for spontaneous regression remain unclear.
Mulder et al. explained the mechanism of spontaneous
regression as follows: “apoptotic events seem to play an
important part, and a local T-cell mediated immune re-
sponse triggered by surgical trauma might also be
involved”. The hypothesis that spontaneous regression
occurs after surgery might help understand this unusualFigure 3 Immunohistochemistry for cytokeratin 20. Most tumor cells e
magnification ×400; (B) original magnification ×600.clinical course. The fact that spontaneous regression was
observed after initial FNA also supports this hypothesis
in our case.
To understand the mechanism of spontaneous regres-
sion further, we studied the expressions of various onco-
genes or tumor suppressor genes, and demonstrated the
expression of Maspin. Maspin belongs to the serine prote-
ase inhibitor family and may be associated with a favorable
prognosis in common salivary gland carcinomas such as
adenoid cystic carcinoma, mucoepidermoid carcinoma
and carcinoma ex pleomorphic adenoma [11]. Although
Maspin expression in salivary SmCC might be important
information, the relationship between Maspin and spon-
taneous regression is under consideration.
Conclusion
The mechanism of spontaneous regression in salivary
SmCC is not fully understood, but our experience with
this case leads us to suggest that some cases have a fa-
vorable clinical outcome that is related to the potential
for spontaneous regression.
Consent
Written informed consent was obtained from the patient’s
guardian for publication of this case report. A copy of the
written consent is available for review by the Editor-
in-Chief of this journal.xpress cytokeratin 20 with a characteristic dot-like pattern. (A) Original
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